Rational Use of Cytotoxic Chemotherapy for Recurrent Ovarian Cancer

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.9, 2006-10, pp. : 947-953

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3741-3753

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy

Current Pharmaceutical Design, Vol. 16, Iss. 4, 2010-02 ,pp. : 411-420

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy for Advanced, Recurrent, and Metastatic Cervical Cancer

By Moore David H.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 1, 2008-01 ,pp. : 53-57

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Patient preferences in advanced or recurrent ovarian cancer

Cancer, Vol. 120, Iss. 23, 2014-12 ,pp. : 3651-3659

Blackwell Publishing

Access to resources Recommend Favorite

Gemcitabine enhances carboplatin for recurrent ovarian cancer

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite